PB2171: THE NOVEL CSN5/JAB1 INHIBITOR CSN5I-3 SUPPRESSES CELL GROWTH AND UPREGULATES GENE EXPRESSION OF TYPE-I INTERFERONS (IFN) IN ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)

• I. Xagoraris,
• G. Kokaraki,
• K. Stathopoulou,
• F. X. Claret,
• E. Drakos,
• G. Z. Rassidakis

Affiliations

I. Xagoraris

1 Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden

G. Kokaraki

1 Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden

K. Stathopoulou

1 Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden

F. X. Claret

2 Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America

E. Drakos

3 Department of Pathology, University of Crete Medical School, Heraklion Crete, Greece

G. Z. Rassidakis

1 Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden